驢跡科技控股(01745.HK):顧劍璐獲委任董事會提名委員會成員
格隆匯6月1日丨驢跡科技控股(01745.HK)宣佈,龍超(公司執行董事兼首席運營官)作為驢跡科技集團有限公司(公司全資附屬公司)僱員的僱傭合約已終止。
鑑於以上情況,董事會已議決暫停龍超的執行董事職責及職務並罷免龍超先生董事會提命委員會成員、公司首席運營官的職位及集團任何其他職位,即時生效,直至刊發進一步通吿。集團產品運營和產品研發將由集團副總經理餘敏帶領的團隊接手工作。公司將會持續引進產品運營、產品研發領域的人才,繼續保持領先於同業的競爭力。
董事會亦宣佈,獨立非執行董事顧劍璐已獲委任為董事會提名委員會成員以替代龍超,即時生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.